Joseph Group Capital Management Buys 310 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Joseph Group Capital Management increased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 9.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,748 shares of the pharmaceutical company’s stock after buying an additional 310 shares during […]

Related Keywords

Canada ,Brucei Sachs ,Ourania Tatsis ,Piper Sandler ,Royal Bank ,Quarter For Vertex Pharmaceuticals ,Joseph Group Capital Management ,Vertex Pharmaceuticals Stock Performance ,Vertex Pharmaceuticals Company Profile ,Vertex Pharmaceuticals ,Nasdaq ,Norges Bank ,Vertex Pharmaceuticals Incorporated ,Securities Exchange Commission ,Capital Research Global Investors ,News Ratings For Vertex Pharmaceuticals Daily ,Free Report ,Group Capital Management ,World Investors ,Research Global Investors ,Pharmaceuticals Incorporated ,Get Free Report ,Director Bruce ,Exchange Commission ,Vertex Pharmaceuticals Daily ,